In the present study, we examined the role of Rheb1 in the MLL-AF9 murine AML model and showed that Rheb1 deletion suppressed AML progression by impairing LSC function and reducing mTORC1 signaling. The gene discussed is RHEBP1; the disease is acute myeloid leukemia.